An interventional study of PEEK in Polyetheretherketone, sponsored by Cairo University. Status unknown. Open to participants aged 40 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-01-02.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
a split mouth randomized clinical trial that compares quantity and quality of bacterial adhesion under both PEEK versus cobalt chromium alloy denture base.
this study aimed to compare the adhesion of microorganisms to the non metallic denture base of PEEK and metallic denture base of cobalt chromium alloy in patients with class III modification 1
241 studies on the registry are indexed under Tissue Adhesions; 29 are open to participants now.
This study's planned enrollment of 2 is below the median of 60 across 184 interventional studies indexed under Tissue Adhesions.
Browse Tissue Adhesions studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
PEEK denture base,
Device: PEEK
cobalt chromium alloy denture base
Device: PEEK
a metallic denture base
Also known as: polyetheretherketone denture base, cobalt chromium alloy denture base
microbial culture using number of clonies after insertion by 3 months
microbial adhesion will be measured using continous cultures to assess number of colonies
Time frame: one year
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University